Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - NeuroBo Pharmaceuticals, Inc. | gemp-20171231ex3219b33e8.htm |
| EX-31.2 - EX-31.2 - NeuroBo Pharmaceuticals, Inc. | gemp-20171231ex31248b761.htm |
| EX-31.1 - EX-31.1 - NeuroBo Pharmaceuticals, Inc. | gemp-20171231ex311622248.htm |
| 10-K - 10-K - NeuroBo Pharmaceuticals, Inc. | gemp-20171231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-222675, Form S-8 No. 333-213946, Form S-8 No. 333-213014, Form S-3 No. 333-220315 and Form S-3 No. 333-217296) of Gemphire Therapeutics Inc. of our report dated March 20, 2018, with respect to the financial statements and schedule of Gemphire Therapeutics Inc. included in the Annual Report on Form 10-K for the year ended December 31, 2017.
/s/ ERNST & YOUNG LLP
Detroit, Michigan
March 20, 2018